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The expression of polyspecific membrane transporters is one important mechanism by which cells 
can obtain resistance to structurally different antibiotics and cytotoxic agents. These transporters 
reduce intracellular drug concentrations to subtoxic levels by mediating drug efflux across the cell 
envelope. The major facilitator superfamily multidrug transporter LmrP from Lactococcus lactis 
catalyses drug efflux in a membrane potential and chemical proton gradient-dependent fashion. To 
enable the interaction with protons and cationic substrates, LmrP contains catalytic carboxyl residues 
on the surface of a large interior chamber that is formed by transmembrane helices. These residues co-
localise together with polar and aromatic residues, and are predicted to be present in two clusters. To 
investigate the functional role of the catalytic carboxylates, we generated mutant proteins catalysing 
membrane potential-independent dye efflux by removing one of the carboxyl residues in Cluster 1. 
We then relocated this carboxyl residue to six positions on the surface of the interior chamber, and 
tested for restoration of wildtype energetics. The reinsertion at positions towards Cluster 2 reinstated 
the membrane potential dependence of dye efflux. Our data uncover a remarkable plasticity in proton 
interactions in LmrP, which is a consequence of the flexibility in the location of key residues that are 
responsible for proton/multidrug antiport.
The ability of microbes to develop resistance to cytotoxic drugs, and to adapt rapidly to changes in the exposure 
to these compounds is an extremely important medical problem1. Drug resistance can be specific for a single 
drug or class of drugs, or occur simultaneously for a wide variety of toxic compounds that are structurally and 
functionally unrelated. The latter phenomenon is called multidrug resistance, and is recognised as an important 
mechanism of bacterial resistance to valuable clinical antibiotics. In many cases, the development of multidrug 
resistance is due to the enhanced expression levels of drug pumps in the cell2. These pumps mediate the extrusion 
of antimicrobials across the cell envelope, away from intracellular targets. Enzyme-ligand interactions are usually 
based on very specific interactions that allow discrimination between enantiomers of the same ligand. The ability 
of multidrug transporters to recognise a broad spectrum of structurally unrelated drugs is intriguing.
Multidrug transporters have been reinvented on multiple occasions in the course of evolution, and are found 
in six different protein families: the ATP-binding cassette (ABC) superfamily, resistance-nodulation-cell division 
(RND) family, multiple antibiotics and toxin extrusion (MATE) family, small multidrug resistance (SMR) family, 
proteobacterial antimicrobial compound efflux (PACE) family, and major facilitator superfamily (MFS)3,4. It is 
generally accepted that members of the ABC family couple drug efflux to ATP binding and hydrolysis, whereas 
the members of the other 5 families operate by a secondary-active transport mechanism in which efflux is cou-
pled to electrochemical ion gradients that exist across the plasma membrane. However, detailed studies on the 
energetics of gram-positive Lactococcus lactis LmrA and gram-negative Escherichia coli MsbA have shown that, 
in addition to the nucleotide dependence, the efflux reactions catalysed by these ABC exporters are also coupled 
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to electrochemical ion gradients5,6. This analogy in energy coupling between classes of multidrug transporters 
makes studies on the underlying mechanisms of ion coupling highly relevant.
LmrP is an MFS multidrug transporter from L. lactis that is relatively well characterised at the functional level7. 
The protein contains 408 amino acids in 12 transmembrane helices (TMs) and connecting loops which, similar 
to many other MFS members, are organised in 2 bundles of 6 TMs in an N- and C-terminal membrane domain8. 
LmrP utilises both the chemical proton gradient (Δ pH, interior alkaline) and membrane potential (Δ ψ , interior 
negative) components of the proton motive force (Δ p)9 to drive electrogenic (membrane potential-dependent) 
propidium efflux from the cell via apparent propidium2+/3H+ antiport10. In an inward-facing three-dimensional 
homology model of LmrP11 based on the crystal structure of the glycerol-phosphate/phosphate antiporter GlpT12, 
the N- and C-terminal membrane domains are suggested to form a large interior chamber containing three car-
boxyl residues (Asp-142, Asp-235 and Glu-327) that are surrounded by polar and aromatic residues. These car-
boxyl residues are predicted to be organised into two catalytic clusters, one containing Asp-235 and Glu-327 in 
the C-terminal domain (Cluster 1) with a distance of ~4.7 Å between the side chain centres and with a known 
ability to coordinate Ca2+ 13, and the other containing Asp-142 in the N-terminal domain (Cluster 2) at a distance 
of ~16.7 Å from Asp-235 and ~16.1 Å from Glu-327 (Fig. 1A). The observed stoichiometry for the electrogenic 
antiport of divalent cationic propidium (3H+/propidium2+) in LmrP, and the effect of carboxyl residue replace-
ments on this stoichiometry suggest that in the propidium transport reaction, Asp-235 and Glu-327 (Cluster 1) 
are important for the interaction of LmrP with 2 protons and the substrate, whereas Asp-142 (Cluster 2) is ded-
icated to the interaction with 1 proton only10. Although each of the two clusters interacts with 1 proton in the 
ethidium transport reaction, none of the three catalytic carboxylates is essential for the interaction of LmrP with 
this monovalent cation10.
To further investigate the functional properties of catalytic carboxylates in LmrP, we changed the composition 
of Cluster 1 by removal of Glu-327, yielding mutant proteins with altered transport properties, and reinserted this 
carboxylate at 6 other positions in the interior chamber (Fig. 1B). Among the tested positions, the relocation to 
positions Thr-331 and Ala-355 towards Cluster 2, restored functional properties of wild-type (WT) LmrP. Our 
data highlight a flexibility in the location of catalytic carboxylates in this multidrug transporter.
Figure 1. Structure models of inward-facing LmrP. (A) LmrP contains two catalytic clusters, Cluster 1 
containing Asp-235 and Glu-327 in the C-terminal domain (red dotted circle), and Cluster 2 containing 
Asp-142 in the N-terminal domain (orange dotted circle)10,11. In addition to these carboxyl residues (in red 
or orange), the clusters also contain one or more aromatic residues (in blue) and polar residues (not shown). 
To investigate the functional role of these catalytic carboxylates and clusters, we changed the composition of 
Cluster 1 by removal of Glu-327 and relocation of this carboxyl residue to 6 positions (in yellow) in the interior 
chamber. Positions for reinsertion of Glu-327 are indicated in smaller, yellow-filled, black rectangles. One of 
these reinsertions, T324E, is partially hidden behind Y323 and E327Q in the figure; the N-terminus is also 
hidden. Helices in front of both clusters (TM 7 [Gln-213 - Ile-231] and TM 12 [Lys-376 - Asn-406] containing 
the C-terminus) are not shown for clarity of presentation. Relocations of Glu-327 from Cluster 1 to positions 
Thr-331 and Ala-355 near Cluster 2 yielded LmrP mutants with a similar functionality as WT LmrP. These 
relocations are indicated by black arrows. (B) Reinserted carboxylates (in yellow) are located on the surface  
(in orange) of the interior chamber in a full model of LmrP. Molecular graphics and analyses were performed 
with UCSF Chimera package (v 1.10.2) and PyMOL Molecular Graphics System (v.1.74). The interior chamber 
was calculated using CASTp cavity analysis29.
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Results
Insertion of carboxyl residues in E327Q LmrP. In transport experiments in the drug-hypersensitive 
Lactococcus lactis NZ9000 ∆lmrA ∆lmrCD expressing LmrP proteins, the ionophores nigericin and valinomy-
cin were employed to selectively manipulate the composition and magnitude of the ∆p. Nigericin mediates the 
antiport of H+ and K+ down their concentration gradients, thereby selectively dissipating ∆pH in an electro-
neutral (membrane potential-independent) manner. Furthermore, valinomycin mediates electrogenic uniport of 
K+, allowing the electrophoretic uptake of K+ in cells with dissipation of the ∆ψ 14. ATP-depleted cells were first 
pre-equilibrated with 2 μ M propidium or ethidium, after which the efflux reaction was initiated with the addi-
tion of 25 mM glucose in the absence and presence of valinomycin and/or nigericin. The control experiments in 
Fig. 2A and B show that WT LmrP mediates ∆ψ and ∆pH-dependent substrate/proton antiport for both propid-
ium and ethidium. As the insertion of extra carboxyl residues with additional proton coupling would yield LmrP 
mutants whose transport reaction is dependent on ∆ψ and ∆pH as seen for WT LmrP, such mutants might not 
be readily detectable. Therefore, we performed our insertion studies in the His6-tagged LmrP mutant in which 
the catalytic carboxyl residue Glu-327 is replaced by the corresponding neutral amide (E327Q). This mutant was 
found to mediate electroneutral proton-substrate antiport for propidium, but electrogenic transport for ethidium 
(Fig. 2C,D). These data have been obtained before10 and are in line with the current results.
An additional carboxyl residue was then introduced in various locations on the surface of the internal binding 
cavity in E327Q LmrP. Locations Thr-33, Ala-53, Asn-123, Thr-324, Thr-331 and Ala-355 were selected using the 
inward-facing three-dimensional LmrP homology model that was previously constructed based on the crystal 
structure of the glycerol-3P/Pi antiporter GlpT11 (Fig. 1A,B). Positions were chosen with respect to their prox-
imity to the catalytic carboxylates Asp-235 (located in Cluster 1) and Asp-142 (located in Cluster 2). In our 
structure model, (i) position 324 is located in closer proximity to Cluster I [Glu-327 (~4.2 Å)/Asp-235 (~6.1 Å)] 
than Cluster II [Asp-142 (~16.6 Å)], (ii) position 331 is located approximately halfway between Cluster I [Glu-
327 (~9.4 Å)/Asp-235 (~11.3 Å)] and Cluster II [Asp-142 (~9.7 Å)], and (iii) position 355 is located in closer 
proximity to Cluster II [Asp-142 (~11.2 Å)] than Cluster I [Glu-327 (~15.9 Å)/Asp-235 (~17.4 Å)]. Positions 33, 
53 and 123 are further away from the two clusters, and are located at the opposite side of the interior chamber 
(Fig. 1B). Secondary mutations T33E, A53E, N123D, T324E, T331E and A355E were subsequently generated in 
Figure 2. Energetics of dye efflux by WT LmrP, E327Q LmrP and E327A LmrP. ATP-depleted cells 
expressing WT LmrP (A,B) and the single mutants E327Q (C,D) or E327A (E,F) were diluted to OD660 of 0.5 
in KPi buffer (pH 7.0) supplemented with 5 mM MgSO4 and pre-equilibrated with 2 μ M propidium (A,C,E) 
or ethidium (B,D,F). Ionophores nigericin or valinomycin or both were added 3 min prior to the addition of 
glucose to measure transport in the presence of ∆ψ or ∆pH only, or without ∆p (Control), respectively. The 
normalised fluorescence start level before glucose addition is set at 100% to facilitate direct comparison of 
data for LmrP mutants with different dye preloading activities. Histograms display the mean ± s.e.m. of dye 
fluorescence end levels in 3 independent experiments with independently prepared batches of cells compared 
to control for which the ∆p was absent (one-way analysis of variance; ****P < 0.0001), and demonstrates the 
reproducibility of data obtained in these assays. Inset in (E) shows the same data as the main figure at a longer 
time scale.
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the background of E327Q LmrP. Western blot analysis of total membrane proteins from inside-out membrane 
vesicles showed that except for A53E/E327Q LmrP, which was expressed at 43% of the expression level of WT 
LmrP, the other mutants showed equal amounts of accumulated protein in the plasma membrane compared to 
WT LmrP (Fig. 3A).
To examine the energetics of LmrP E327Q mutants with an inserted carboxyl residue, propidium efflux in 
intact cells was measured in the absence or presence of ionophores as described for Fig. 2. The introduction of E at 
position 331 substantially restored electrogenic propidium transport pointing to the ability of the T331E/E327Q 
double mutant to utilise both the ∆ pH and the ∆ ψ in the efflux reaction (Fig. 3B). In contrast, the double mutants 
A355E/E327Q and N123D/E327Q showed propidium efflux activity in the presence of either the ∆ p or the 
∆ pH, but negligible transport activity in the presence of the ∆ ψ only (Fig. 3C,D). These mutants therefore display 
the same phenotype as the single mutant E327Q background in which the mutations were generated. The double 
mutants T324E/E327Q, T33E/E327Q and A53E/E327Q (Fig. 3E–G) did not mediate detectable propidium efflux 
in the presence of ∆ p or its components. As all mutants were expressed in the plasma membrane (Fig. 3A), these 
data suggest that an acidic residue in position 33, 53 and 324 somehow interferes with the propidium transport 
reaction.
Figure 3. Expression and activity of E327Q LmrP mutants with a reinserted carboxyl residue.  
(A) Immunodetection of total membrane proteins in plasma membrane vesicles (10 μ g of protein/lane) 
containing WT LmrP or mutants LmrP, or no LmrP protein (Ctrl). Proteins were transferred from SDS-PAGE 
gel to HybondP membrane by electroblotting and probed with anti-His-tag and secondary antibodies. For 
clarity of presentation, blot was cropped in Adobe Illustrator CC 2015.3; full-length blot is available at  
http://dx.doi.org/10.17863/CAM.6219. (B) Cells expressing the T331E/E327Q double mutant LmrP were 
diluted in KPi buffer (pH 7.0) supplemented with 5 mM MgSO4 and pre-equilibrated with 2 μ M propidium. 
(C–G) Transport experiments as in (B) for A355E/E327Q (C), N123D/E327Q (D), T324E/E327Q (E), T33E/
E327Q (F), and A53E/E327Q (G). See legend to Fig. 2 for further details. Data represent observations in 3 or 
more independent experiments with independently prepared batches of membrane vesicles or cells. Values in 
histograms are expressed as mean ± s.e.m. (one-way analysis of variance; ****P < 0.0001).
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Insertion of carboxyl residues in E327A LmrP. To examine changes in ethidium transport for the car-
boxylate insertion mutants, Glu-327 was replaced by A in His6-tagged LmrP. In control experiments, the single 
mutant E327A showed active propidium and ethidium efflux in the presence of the ∆p (interior negative and alka-
line) or its ∆pH component, while transport activity was reduced to a negligible level with the ∆ψ only (Fig. 2E,F). 
Thus, E327A LmrP mediates electroneutral transport of these cationic dyes, and provides an ideal background to 
test for carboxylate insertions that restore the ∆ψ dependence in ethidium transport.
The carboxylate substitutions at positions 324, 355 and 331 were selected for further experiments as they rep-
resent the three categories of mutants that were encountered in the propidium transport experiments in E327Q 
LmrP (Fig. 3): transport-inactive, tolerated but silent, and catalytically-active relocations of Glu-327, respec-
tively. Double mutants T331E/E327A and A324E/E327A were equally well expressed as WT LmrP in the plasma 
membrane of L. lactis, whereas A355E/E327A was expressed at 68% of the WT level (Fig. 4A). To test whether 
the introduction of the carboxyl residues on the surface of the internal cavity can restore the ability of the E327A 
mutant to mediate ∆ ψ -dependent ethidium transport, similar substrate efflux assays were carried out as described 
for the E327Q proteins (Fig. 3). In experiments with propidium, comparable results were obtained in the E327A 
background as for E327Q (Fig. 4B–D). For ethidium transport, the introduction of E at position 331 and 355 in 
E327A LmrP, each supported ∆ ψ -dependent transport (Fig. 4E,F). Although A355E/E327A showed a weaker 
activity in ∆ ψ -dependent ethidium transport compared to T331E/E327A, the activity of A355E/E327A was sig-
nificant compared to E327A LmrP (Fig. 2F) (P < 0.01). Mutant T324E/E327A transported ethidium (Fig. 4G) in 
a comparable fashion as E327A LmrP but at lower rates (Fig. 4B) suggesting that T324E is not catalytically active 
in ethidium transport in the E327A background but that the replacement is tolerated. Taken together, T331E and 
A355E are the only carboxyl residues in our test panel that impose electrogenicity on transport, for T331E, of 
propidium and ethidium transport, and for A355E, of ethidium transport only. These carboxylates are therefore 
most likely functional in proton coupling with these substrates.
The effect of the T331E replacement on the affinity of E327A LmrP for propidium and ethidium was eval-
uated by measuring the kinetics of facilitated substrate influx in ATP-depleted cells. Following the addition of 
propidium or ethidium at concentrations ranging from 1 μ M to 30 μ M, the rates of substrate uptake over the 
initial 30 s were determined. These rates were corrected for dye influx in control cells without LmrP expression, 
and were subsequently plotted against the substrate concentration (Fig. 4H,I). The propidium binding affinity of 
T331E/E327A LmrP (expressed as the substrate concentration Kt giving a half-maximal rate of transport Vmax) 
was similar in comparison to WT LmrP (Kt = 2.5 ± 0.4 μ M versus 1.3 ± 0.2 μ M). Similarly, no significant differ-
ence was observed for ethidium in this comparison (Kt = 8.1 ± 5.3 μ M versus 7.7 ± 5.1 μ M). Furthermore, the 
Vmax values for dye uptake by T331E/E327A LmrP were similar to those obtained for WT LmrP (propidium, 
Vmax = 3.9 ± 0.2 A.U./s versus 3.1 ± 0.1 A.U./s; ethidium, Vmax = 4.3 ± 1.5 A.U./s versus 4.3 ± 1.4 A.U./s). As the 
rates of facilitated dye uptake by E327A LmrP were too low for kinetic analysis, the data suggest that insertion of 
E at position 331 in the E327A background restores the transport capabilities of the single mutant to those of WT 
LmrP, and hence, that T331E compensates for the loss of E at position 327.
T331E substitution in WT LmrP. As a carboxyl residue at position 331 is functionally active in drug/pro-
ton antiport in E327Q and E327A mutants, the effect of this replacement was also tested in the WT background 
(Fig. 5). The T331E mutant was generated in His10-tagged LmrP, and expressed to a similar level as WT (Fig. 5A). 
It was found that T331E LmrP mediates propidium efflux to a lower steady-state level compared to WT LmrP 
(Fig. 5B), which is consistent with the increased propidium resistance of T331E LmrP-expressing cells compared 
to WT LmrP-expressing cells (Fig. 5D). For ethidium, T331E LmrP showed a similar transport as WT LmrP 
(Fig. 5C). To delineate whether the enhanced propidium transport by T331E LmrP was due to enhanced proton 
coupling and/or enhanced interaction with propidium, the binding affinity of T331E LmrP for propidium was 
first measured using the facilitated influx assay in lactococcal cells as described for T331E/E327A LmrP (Fig. 4H). 
The Kt of T331E LmrP and WT LmrP for propidium was found not to be significantly different, 1.2 ± 0.4 μ M and 
1.3 ± 0.3 μ M, respectively. Furthermore, propidium binding to purified T331E LmrP and WT LmrP was meas-
ured by fluorescence anisotropy (Fig. 5F). In this assay, propidium at a fixed concentration of 1 μ M or 0.2 μ M 
was titrated with increasing concentrations of purified protein in detergent solution until a steady level of fluo-
rescence anisotropy was achieved. These fixed ligand concentrations are in the same range or 5 to 10-fold below 
the apparent Kt of Wt LmrP and T331E LmrP for propidium, and hence, enable propidium binding in a protein 
concentration-dependent, hyperbolic fashion (Fig. 5F). As the measurements yielded binding data for Wt LmrP 
and T331E LmrP that were overlapping, these data indicate that there was no significant difference in the propid-
ium binding affinity of both proteins.
The effect of the insertion of T331E in WT LmrP on the energetics of transport was tested in proteolipos-
omes in which purified LmrP or T331E LmrP were functionally reconstituted at equal levels in the phospholipid 
bilayer (Fig. 6A). In this system, dye accumulation was monitored by fluorimetry through inclusion of 1 mg/ml 
sheared calf thymus DNA in the lumen of the liposomes6. For the imposition of the ∆ p, a transmembrane ∆ pH 
(interior acidic) and ∆ ψ (interior positive) were imposed artificially by the preparation of the (proteo) liposomes 
in NH4SCN containing buffer (pH 6.8), and subsequent 100-fold dilution in NH4SCN-free buffer (pH 7.5), thus 
allowing the passive diffusion of NH3 and SCN− to the external buffer6. With the addition of 2 μ M propidium to 
the external buffer, a significantly higher ∆ p-dependent accumulation of propidium was obtained in proteolipos-
omes containing T331E LmrP compared to WT LmrP, whereas the no gradient controls showed a similar low 
background-level fluorescence (Fig. 6B). In contrast, when 2 μ M ethidium was added in the assay a similar level 
of ethidium accumulation was observed for both T331E and WT LmrP compared to the no gradient controls 
(Fig. 6C). The basic thermodynamic relationship between the driving force and the propidium concentration 
gradient across the proteoliposomal membrane at equilibrium is given by:
www.nature.com/scientificreports/
6Scientific RepoRts | 6:38052 | DOI: 10.1038/srep38052
Figure 4. Expression and activity of E327A LmrP mutants with a reinserted carboxyl residue.  
(A) Immunodetection of total membrane proteins in plasma membrane vesicles (10 μ g of protein/lane) 
containing WT LmrP or mutants LmrP, or without LmrP protein (Ctrl). Full-length blot is available at  
http://dx.doi.org/10.17863/CAM.6219. (B–G) Cells expressing the double mutants T331E/E327A (B,E),  
A355E/E327A (C,F) and T324E/E327A (D,G) were diluted in KPi buffer (pH 7.0) supplemented with 5 mM 
MgSO4, and were pre-equilibrated with 2 μ M propidium (B–D) or ethidium (E–G). See legend to Fig. 2 for 
further details (*P ≤ 0.05). Inset in (C) shows the same data as the main figure at a longer time scale.  
(H,I) Kinetics of facilitated propidium and ethidium influx by WT LmrP and LmrP mutants. ATP-depleted 
cells expressing WT LmrP (● ), the single mutant E327A (▲ ) and double mutant T331E/E327A (■ ) were 
diluted in KPi buffer (pH 7.0) supplemented with 5 mM MgSO4, after which propidium (H) or ethidium 
(I) was added. The rates of influx were calculated over the initial 30 s and plotted against the dye concentration 
as the mean ± s.e.m; values in histograms are expressed as mean ± s.e.m. (one-way analysis of variance; 
*P < 0.05; ***P < 0.001; ****P < 0.0001). The error bars for some of the data points in (H,I) are too small to be 
displayed, and are hidden behind the data point symbols. Data represent observations in 3 or more independent 
experiments with independently prepared batches of membrane vesicles or cells.
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Figure 5. Comparison of the expression and activity of T331E LmrP versus WT LmrP. (A) Immunodetection 
of total membrane proteins in plasma membrane vesicles (10 μ g of protein/lane) containing WT LmrP or T331E 
LmrP. Full-length blot is available at http://dx.doi.org/10.17863/CAM.6219. (B,C) Dye transport in intact cells. 
ATP-depleted cells expressing WT LmrP and the single mutant T331E were diluted in buffer, and pre-equilibrated 
with 2 μ M propidium (B) or ethidium (C). Histograms show significant differences between fluorescence end 
levels for transport of propidium but not ethidium. (D) Measurement of the growth rate (A.U./s) of cell cultures as 
a function of propidium concentration shows that T331E LmrP expression confers increased resistance on the cells 
compared to WT LmrP. (E) Kinetics of facilitated propidium influx in ATP-depleted cells containing WT LmrP 
(● ) or T331E LmrP (▼ ). (F) Propidium binding to WT LmrP and T331E LmrP. Purified protein in detergent 
solution was added stepwise to buffer containing 0.2 μ M propidium (top) or 1 μ M propidium (bottom), after which 
the fluorescence anisotropy was measured. Elution buffer without protein served as the control (○ ). Data represent 
observations in 3 or more independent experiments with independently prepared batches of membrane vesicles 
or cells. Values in data points and histograms are expressed as mean ± s.e.m. (A–C) unpaired student t-test; (D–F), 
one-way analysis of variance; **P < 0.01). The error bars for the data points in (D,F) are too small to be displayed, 
and are hidden behind the data point symbols.
www.nature.com/scientificreports/
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in which Z = 2.3RT/F = approx. 59 mV at 25 °C, and n is the number of H+ that participates in the antiport reac-
tion. The elevated propidium accumulation level in proteoliposomes for ∆ p-dependent transport by T331E LmrP 
compared to WT LmrP (Fig. 6D) therefore indicates a higher value of n for T331E LmrP in the propidium trans-
port reaction. This conclusion is also in agreement with propidium efflux measurements in cells showing efflux to 
lower end levels for T331E LmrP compared to WT LmrP (Fig. 5B).
Taken together, these data suggest that the enhanced propidium transport activity of T331E LmrP compared 
to WT LmrP is not due to enhanced interaction of the mutant with propidium but that the extra carboxyl residue 
introduced at position 331 functions as an additional proton-binding site in the propidium transport reaction.
Figure 6. Dye transport in proteoliposomes. (A) Immunodetection of his-tagged protein shows  
that equal amounts of WT LmrP or T331E LmrP protein were incorporated in the proteoliposomal 
membrane, and that the empty control liposomes (Ctrl) were devoid of LmrP. Full-length blot is available 
at http://dx.doi.org/10.17863/CAM.6219. (B–D) Proteoliposomes were diluted to impose an artificial ∆ p 
(interior positive and acidic) or no gradient. At the arrow, 2 μ M propidium (B) or ethidium (C) was added, after 
which dye accumulation was measured over time by fluorimetry. Steady-state fluorescence levels (D) at approx. 
400 s suggests a significantly elevated level of propidium accumulation for T331E LmrP compared to WT LmrP. 
Line colours in (B,C) are the same as bar colours in (D) and refer to the same experimental conditions.  
No significant difference was observed for ethidium in this comparison. Data represent observations in 
3 or more independent experiments with independently prepared batches of proteoliposomes. The mean 
fluorescence level in the absence of ∆p was set at 100%. Values in histograms are expressed as mean ± s.e.m.  
(A) unpaired student t-test; (D), two-way analysis of variance; **P < 0.01; ****P < 0.0001).
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Discussion
Although previous work identified three catalytic carboxylates in LmrP (Asp-142, Asp-235 and Glu-327), it was 
suggested that these carboxylates only form two proton binding groups in the transport reaction for monova-
lent ethidium10. In the presence of ethidium, Glu-327 and Asp-235 in wild-type LmrP are proposed to form 
a carboxyl-carboxylate pair containing Asp-235 as a single proton acceptor moiety that is stabilized through 
hydrogen bonding with the adjacent undissociated carboxyl moiety in Glu-327 or amide moiety in E327Q. This 
stabilization is likely to elevate the pKa of Asp-235 to a value closer to the physiological intracellular pH where 
Asp-235 becomes a functional proton binding group. Therefore, the Δ p dependence of ethidium transport is 
similar for wildtype (Glu-327) and the E327Q mutant in the experiments in Fig. 2B and D, and reflects apparent 
electrogenic 2H+/ethidium+ antiport. However, when E327Q is replaced by E327A the lower pKa of Asp-235 
would disable this carboxyl group in proton binding under physiological conditions, yielding apparent electro-
neutral 1H+/ethidium+ antiport as observed in our data (Fig. 2F). When divalent cationic propidium is bound on 
the surface of the interior chamber of LmrP, Glu-327 and Asp-235 might not directly interact with each other due 
to changes in the distance and geometry of their side chains compared to the ethidium-bound state, and both car-
boxyl residues now function as independent proton acceptor moieties10. Such changes in side-chain interactions 
in response to the binding of different substrates have been observed in co-crystal structures of the multidrug 
binding transcriptional repressor QacR15,16. Together with Asp-142, the independent activities of Asp-235 and 
Glu-327 in LmrP now result in apparent electrogenic 3H+/propidium2+ antiport. Consistent with the experimen-
tal data for E327Q (Fig. 2C) and E327A (Fig. 2E), this stoichiometry is reduced to apparent electroneutral 2H+/
propidium2+ antiport upon the loss of Glu-327.
Using rational design, we modified the relative distance between the membrane-embedded carboxyl residues 
in the interior chamber of LmrP. Out of the 6 tested positions, T331E recovered WT-like electrogenic transport 
for propidium and ethidium in E327A LmrP, whereas A355E recovered electrogenic transport for ethidium but 
not for propidium in this background. The T331E substitution also recovered WT-like propidium transport capa-
bilities in the E327Q background. These findings point to a functional redundancy between T331E and Glu-327. 
In these experiments, the deleted Glu-327 carboxylate migrates from being close to Asp-235 (~4.7 Å) to positions 
where it has a large distance from Asp-235, ~11.3 Å in the case of T331E, and ~17.4 Å in the case of A355E, and 
where this carboxylate is functionally active in proton coupling. This result demonstrates the plasticity in the loca-
tion of proton-binding moieties in LmrP. As the T331E and A355E mutations involve the relocation of Glu-327 
from Cluster 1 towards Cluster 2, our data point to the existence of an area in the interior chamber, with Cluster 
1 and 2 at its boundaries, in which carboxylates are active in proton-coupling.
The transport measurements indicate that the insertion of T331E in WT LmrP allows the mutant transporter 
to sustain a larger inwardly directed propidium concentration gradient in cells, and outwardly directed propid-
ium concentration gradient in proteoliposomes in which the transporter is inserted in an inside-out fashion. 
Together with the observations on ∆ p-dependent propidium transport in proteoliposomes, these results strongly 
suggest that T331E acts as proton binding group in addition to the existing Asp-142, Asp-235 and Glu-327. The 
established stoichiometry of 3H+/propidium2+ for WT LmrP10 will therefore most likely increase to 4H+/propid-
ium2+. This conclusion is consistent with recent observations on the MFS transporter MdfA from E. coli showing 
that an increase in proton/drug stoichiometry requires an additional acidic residue in the multidrug recognition 
pocket of this transporter17. As the insertion of T331E in Wt LmrP did not enhance the ethidium concentration 
gradients in cells and proteoliposomes, T331E might share a functional similarity with Glu-327 in that neither of 
these carboxylates appears to play an active role in proton coupling during the ethidium transport reactions by 
T331E LmrP and Wt LmrP (see discussion for Glu-327 in Wt LmrP above). Our detailed understanding of these 
phenomena will require the high-resolution structural elucidation of the ethidium-LmrP and propidium-LmrP 
complexes in which the side-chain interactions of Asp-142, Asp-235, Glu-327 and T331E in inward-facing and 
outward-facing states of LmrP are resolved.
Similar to the native catalytic carboxylates Glu-327 and Asp-235, the newly introduced T331E and A355E are 
located in the C-terminal half of LmrP. As none of the other substitutions at the positions 33, 53 and 123 in the 
N-terminal half was catalytically active, the data suggest that although, like MdfA, LmrP is promiscuous regard-
ing the positions where carboxyl residues can be functionally inserted, a bias might exist towards positions in the 
C-terminal half. This finding is reminiscent of previous observations on the MFS oxalate transporter OxlT, a GlpT 
homolog from Oxalobacter formigenes18. The ligand-binding residues in OxlT all lie in the C-terminal domain 
(on TM8 and TM11), whereas those in the glycerol-phosphate/phosphate antiporter GlpT lie at symmetrical 
positions (on TM1 and TM7) at the interface between the N- and C-terminal halves19.
Secondary-active multidrug transporters can confer drug resistance on the cell by facilitating active drug 
export across a plasma membrane that provides a barrier for passive influx of drugs20. Drugs can be expelled 
against their concentration gradient or lipid-water partition coefficient by coupling drug extrusion to the move-
ment of protons and/or sodium ions down their electrochemical gradient. Our understanding of the mechanistic 
principles behind this biochemical coupling process requires knowledge of the ion translocation pathway(s), as 
well as the link between ion movement and conformational changes within the transporter that result in alter-
nating access of drug binding surfaces. The mechanism of LacY has been intensely studied21–23, and was found to 
rely on proton binding to critical carboxylates, the dissociation of which is based on competitive binding of the 
cationic side chain of a neighbouring basic residue. The location of these catalytic carboxylates is therefore very 
precise and crucial for transport activity. A similar type of mechanism is also relevant for proton coupling in the 
trimeric RND multidrug transporter AcrB, where Lys-940, Arg-971, Asp-407 and Asp-408 are part of a proton 
relay network within the membrane domain of each AcrB protomer. This network is functionally coupled to 
drug binding at, and drug translocation through, the periplasmic domains in the AcrB trimer24. Previous studies 
on basic residues in LmrP highlighted the important role of Arg-260 and Lys-337 in the functional properties 
of this transporter25. Although these residues are predicted in our structure model to be oriented towards the 
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head group region of the outer leaflet (Arg-260) and inner leaflet (Lys-357) of the cytoplasmic membrane, helical 
rotations during the transport cycle or a small 1 to 2 residue shift of the polypeptide in our structure model could 
place these basic residues in the central cavity where they might directly interact with the catalytic carboxylates. 
However, the protonation state of the catalytic carboxylates in LmrP could also be regulated by mechanisms that 
do not require the proximity of basic residues, e.g. by conformation-dependent changes in the physico-chemical 
properties of the local environment near the catalytic clusters. If relevant, the lack of AcrB and LacY-type ste-
reospecific proton dissociation mechanisms in LmrP could be one of the reasons why this transporter tolerates 
relocations of carboxylates between cluster regions in which these carboxylates are catalytically active in proton/
drug antiport.
In conclusion, our data suggest that LmrP exhibits a plasticity in proton interactions due to the intrinsic 
flexibility in the location of the key residues that are responsible for proton/drug exchange. This flexibility ena-
bles LmrP to rapidly evolve its polyspecificity through the acquisition of mutations while retaining proton/drug 
antiport activity.
Methods
Bacterial strains, protein expression, and site-directed mutagenesis. The His6-tagged lmrP 
wild type and mutant genes were cloned in the pNZ8084 plasmid downstream of the nisA promoter region7,26. 
Plasmids were maintained in the drug-hypersensitive L. lactis NZ9000 Δ lmrA Δ lmrCD27 lacking endogenous 
multidrug efflux pumps, which was grown at 30 °C in M17 broth (Oxoid) supplemented with 25 mM glucose 
and 5 μ g/ml chloramphenicol. The cells were grown to an OD660 of 0.5–0.6 after which the protein expression 
was induced for 2 h by the addition of a 1:1000 dilution of nisin A-containing supernatant of the nisin-producing 
L. lactis strain NZ970026 (approx. final concentration of 10 pg/ml of nisin A). The construction of lmrP mutants 
was carried out using the QuikChange method (Agilent Technologies) with mutagenic primer pairs as listed in 
Table 1. DNA was sequenced to ensure that only the intended changes were introduced.
Transport measurements in intact cells. Cells were harvested by centrifugation at 6,500 x g for 10 min at 
4 °C and washed once with 50 mM KPi (pH 7.0) containing 5 mM MgSO4. Harvested cells were then de-energised 
in the presence of 0.5 mM of the uncoupler dinitrophenol for 30 min at 30 °C to deplete ATP28. The de-energised 
cells were subsequently washed 3 times with ice-cold buffer, resuspended to an OD660 of 5.0, and kept on ice to 
maintain their viability. For monitoring active efflux, cells were diluted in prewarmed buffer to OD660 of 0.5, and 
equilibrated with 2 μ M of either ethidium or propidium (fluorescence level of ~150 A.U. was obtained for propid-
ium and up to ~250 A.U. for ethidium). Once the saturation level was obtained, 25 mM glucose was added as the 
source of energy and active efflux of the dye was measured by fluorimetry. The data were normalised by taking 
the fluorescence start level before the addition of glucose as 100% for direct comparison of data for LmrP mutants 
with different dye preloading activity. Where indicated, valinomycin was added 3 min before glucose addition 
at a concentration of 0.5 μ M. Nigericin was added at a concentration of 0.5 μ M for E327Q mutants and 1 μ M for 
E327A mutants. Fluorescence measurements were performed in a Perkin Elmer LS-55B at λ excitation of 500 nm and 
λ emission of 580 nm with slit widths of 5 and 10 nm, respectively, for ethidium, and λ excitation at 535 nm and λ emission 
at 617 nm with slit widths of 10 nm each for propidium. For measurements of the kinetics of facilitated dye influx, 
cells were diluted 10-fold in 2 ml of buffer. Propidium or ethidium was added to final concentrations between 1 μ M 
and 10 μ M, and influx was monitored over the first 100 s.
Preparation of inside-out membrane vesicles and protein purification. Inside-out membrane ves-
icles were prepared using as Basic Z 0.75-kW Benchtop Cell Disruptor as described10. The expression levels of 
the his-tagged LmrP proteins in the lactococcal plasma membrane vesicles were compared on immunoblot that 
was probed with primary mouse anti-polyhistidine tag antibody (Sigma-Aldrich, Cat. No.: H1029) and second-
ary goat anti-mouse antibody (Sigma-Aldrich, Cat. No.: A4416). LmrP signals were quantified by densitometric 
analysis of three independent blots using ImageJ software, version 1.43 (National Institutes of Health). For clarity 
of presentation, immunoblots in main figure panels were cropped in Adobe Illustrator CC 2015.3. The complete 
immunoblots are available at http://dx.doi.org/10.17863/CAM.6219.
Membrane vesicles were solubilised at a protein concentration of 5 mg/ml in a solubilisation buffer containing 
50 mM KPi (pH 8.0), 100 mM NaCl, 10% (v/v) glycerol, 1 mg/ml protease inhibitor cocktail and 1% β-D-dodecyl 
T33E Fw
a: GGC ACC GTT TTT TCT TCA ATG GAG ATT TAT TAT AAT C  
Rv: G ATT ATA ATA AAT CTC CAT TGA AGA AAA AAC GGT GCC
A53E Fw: C TTA TCT GAG GTG GCA ACT TTT GTC GCC  Rv: GGC GAC AAA AGT TGC CAC CTC AGA TAA G
N123D Fw: GTG ATA ACT GCT GGG GAT GCC ATG  Rv: CAT GGC ATC CCC AGC AGT TAT CAC
T324E Fw: GCA GGT ATT GTT TAT GAG TTG GGT CAG ATT GTT TAT ACC  Rv: GGT ATA AAC AAT CTG ACC CAA CTC ATA AAC AAT ACC TGC
T331E Fw: G GGT GAG ATT GTT TAT GAG CCA AGT GTT C  Rv: G AAC ACT TGG CTC ATA AAC AAT CTC ACC C
A355E Fw: GC GTT GCA GAG ATT AAA ATG CC  Rv: GG CAT TTT AAT CTC TGC AAC GC
Table 1.  Sequences of PCR primers used for the generation of LmrP mutants. aFw = forward primer, 
Rv = reverse primer, base substitution in codon in bold.
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maltoside (DDM) (Melford and Anatrace). The solubilisation sample was incubated on a rotating wheel for 4 h 
at 4 °C. Insoluble material was removed by ultracentrifugation at 125,000 x g for 1 h at 4 °C. The supernatant 
was added to nickel-nitrilotriacetic acid (Ni-NTA, 1 ml of resin per 10 mg of his-tagged protein)-agarose resin 
(Sigma), previously equilibrated by two washes with five resin volumes of Milli-Q water and two washes with five 
resin volumes of Buffer A (50 mM KPi (pH 8.0), 100 mM NaCl, 10% (v/v) glycerol, 0.05% (w/v) DDM and 20 mM 
imidazole). The resin-binding mix was incubated on a rotating wheel at 4 °C overnight. The resin was transferred 
to a 2 ml Bio-spin chromatography column (Bio-Rad), washed with two column volumes of Buffer A and two col-
umn volumes of Buffer B (50 mM KPi (pH 7.0), 100 mM NaCl, 10% (v/v) glycerol, 0.05% (w/v) DDM and 20 mM 
imidazole), and eluted with two resin volumes of Buffer C (Buffer B supplemented with 200 mM imidazole and 
5% glycerol). Protein concentrations were determined using the Micro-BCA assay kit (Pierce).
Transport measurements in proteoliposomes. Purified LmrP WT or LmrP T331E protein was func-
tionally reconstituted into liposomes by described methods6 in preparation buffer (pH 6.8) containing 10 mM 
K-Hepes, 100 mM K2SO4, 100 mM NH4SCN, and 1 mg/ml of sonicated calf thymus DNA (Trevigen). Purified 
protein was added at a lipid:protein ratio of 50:1 (w/w) to Triton X-100-destabilised liposomes, and the mix-
ture was incubated for 30 min at room temperature. Detergent was removed by incubation with SM2 biobeads 
as described6. Subsequently, the proteoliposomes were incubated for 15–20 min with DNase (10 μ l/ml) in the 
presence of 10 mM MgSO4 to remove any DNA contamination from the lipid bilayer, collected by centrifuga-
tion at 165,145 × g for 30 min, resuspended in 150–200 μ l of preparation buffer, and used immediately in trans-
port assays. For measurements of ethidium and propidium transport in (proteo)liposomes in the presence of an 
imposed Δ p (inside acidic and negative), the proteoliposomes were diluted 100-fold in dilution buffer (pH 7.5) 
containing 10 mM K-Hepes and 100 mM K2SO4 in a total reaction volume of 2 ml. Ethidium or propidium was 
added to a final concentration of 2 μ M, and transport was monitored in a Perkin Elmer LS-55B fluorimeter.
Fluorescence anisotropy. Protein purification was done as described under “Preparation of inside-out mem-
brane vesicles and protein purification” and the purified protein was diluted to a concentration of 0.4 mg/ml in 2 ml 
of 50 mM KPi buffer (pH 7.0) supplemented with 100 mM NaCl, 0.05% DDM, and 1 μ M or 0.2 μ M propidium. For 
propidium binding measurements, the purified protein was added in 3 steps of 3.45 μ g each, followed by 1 step of 
7.0 μ g, 3 steps of 17.3 μ g, 1 step of 3 μ g and 1 step of 17 μ g. Equivalent amounts of elution buffer (Buffer C under 
“Preparation of inside-out membrane vesicles and protein purification”) were added in a protein-free control sample.
Drug resistance. L. lactis was grown in M17 medium supplemented with 25 mM glucose and 5 μ g/ml chlo-
ramphenicol. After 16 h of growth at 30 °C, cell cultures were used to inoculate fresh medium at a 1:50 (v/v) dilu-
tion. At OD660 of 0.5, protein production was initiated through the addition of 10 pg/ml nisin. Protein expression 
was induced for 2 h, after which the culture was diluted 1:10 (v/v) in fresh medium supplemented containing 
10 pg/ml nisin in the wells of a 96-well plate. Propidium was then added at concentrations as indicated in Fig. 5D. 
The wells were covered with 25 μ l of sterile mineral oil to reduce evaporation of water. The growth of cultures in 
the wells at 30 °C was recorded by measuring the OD660 in a Versamax microplate reader (Molecular Devices) 
over a time period of 16 h. Cultures were grown in triplicates for each propidium concentration. The slopes of the 
exponential phase in growth curves were determined from the linear increase in a log10(OD660) versus time plot, 
and were plotted against the corresponding propidium concentration in Fig. 5D.
Statistical analyses. The data points plotted for immuno blots and fluorescence studies are obtained in at least 
3 independent experiments using separate batches of intact cells, membrane vesicles, or proteoliposomes and statis-
tical parameters are plotted using GraphPad Prism 6 software. Histograms display the mean ± s.e.m., and demon-
strate the reproducibility of the experiments. Means of the fluorescence end levels of Δ p, Δ ψ and Δ pH-dependent 
dye transport in cells were compared with that of the control. Statistical analyses were performed using one-way 
analysis of variance (ANOVA). For Figs 5A–C and 6A the two-tailed student t-test was used. In proteoliposomes 
(Fig. 6D), steady-state levels of the normalised fluorescence were compared with that of the control without the 
imposed Δ p. These analyses were performed by two-way ANOVA holm-sidak’s multiple comparison test. In the 
histograms, significance is shown by asterisks: ****P < 0.0001; ***P < 0.001; **P < 0.01; *P < 0.05; no asterisk, not 
significant. For studies on energetics of transport, asterisks directly above bars in the histograms refer to comparison 
with condition without Δ p; asterisks above lines refer to specific comparisons.
Data Availability. A previous version of this manuscript was withdrawn by the authors from publication in 
the Journal of Biological Chemistry (jbc.M115.694901). The figures in the current publication are based on new 
and original data which were generated in triplicate or more, and which have been deposited in the University of 
Cambridge data repository with accession link http://dx.doi.org/10.17863/CAM.6219.
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